Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Brelovitug 300 mg
Mirum Pharmaceuticals International B.V.
Chronic Hepatitis D Infection
3 trials -
CDZ173/Leniolisib, CDZ173/Leniolisib
Pharming Technologies B.V.
Activated Phosphoinositide 3-Kinase Delta Syndrome
1 trial -
CDZ173/Leniolisib, CDZ173/Leniolisib, CDZ173/Leniolisib
Pharming Technologies B.V.
Activated Phosphoinositide 3-Kinase Delta Syndrome
1 trial -
CHLORURE DE POTASSIUM B. BRAUN 10 % (0,10 g/ml), solution à diluer pour perfusion, GLUCOSE 2,5 % B. BRAUN, solution pour perfusion, MINIRIN 4 microgrammes/ml, solution injectable, SODIUM LACTATE, CHLORURE DE SODIUM 0,9 % AGUETTANT, solution pour perfusion, CHLORURE DE SODIUM HYPERTONIQUE 10 % LAVOISIER, solution à diluer injectable, GLUCOSE 5 % VIAFLO, solution pour perfusion, GADOTERIC ACID
Pari Pharma GmbH
Severe hyponatremia and a high risk of rapid SNa overcorrection
1 trial -
CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule, TOCILIZUMAB
Pari Pharma GmbH
Sickle cell disease
1 trial -
COAGULATION FACTOR VIII , COAGULATION FACTOR VIIA , COAGULATION FACTOR IX , SAR439774, FACTOR VIII INHIBITOR BYPASSING ACTIVITY , ANTITHROMBIN III
Genzyme Europe B.V.
Hemophilia A or Hemophilia B
1 trial -
CRT with triple site ventricular stimulation
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Carbetocin
Acadia Pharmaceuticals B.V.
Hyperphagia in Prader-Willi Syndrome
2 trials -
Cholic Acid
Mirum Pharmaceuticals International B.V.
Bile Acid Synthesis Defect
1 trial -
Cholic Acids
Mirum Pharmaceuticals International B.V.
Infantile Refsum's Disease
1 trial -
Cholic acid
Mirum Pharmaceuticals International B.V.
Inborn Errors of Bile Acid Synthesis
1 trial -
Cisplatin Hikma 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Zipalertinib, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion
Taiho Pharma Netherlands B.V.
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
1 trial -
Class I or III Antiarrhythmic Medications
Rhythm Pharmaceuticals Netherlands B.V.
Atrial Fibrillation
1 trial -
Coronary artery bypass grafting
Rhythm Pharmaceuticals Netherlands B.V.
Ischemic Heart Failure
1 trial -
DTG + 3TC
ViiV Healthcare B.V.
HIV Infections
1 trial -
DUOFAG, Chlorid sodný B. Braun 0,9 % infuzní roztok
Lacuna Pharma Pty Ltd
Complicated skin wounds (wounds healing per secundam via granulation tissue) - either as a complication of healing of acute wounds (infected surgical or traumatic wounds) or chronic wounds, in both cases infected with S. aureus and/or P. aeruginosa.
1 trial -
Dolutegravir/abacavir/lamivudine FDC
ViiV Healthcare B.V.
Infection, Human Immunodeficiency Virus
1 trial -
Double-blind 200 mg imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Elenestinib
Blueprint Medicines (Netherlands) B.V.
Indolent Systemic Mastocytosis
1 trial -
Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat
Genzyme Europe B.V.
Gaucher's disease type I; Gaucher's disease type III
1 trial -
Everolimus-ratiopharm® 2,5 mg Tabletten, GOSERELIN , ORSERDU 86 mg film-coated tablets, ORSERDU 345 mg film-coated tablets, LEUPRORELIN , DEXAMETHASONE , The investigational product is as follows: white tablets, elongated, flat, rounded edges, about 10 mm long and 4 mm wide, with the embossing "EV" on one side and "2.5" on the other side. The list of excipients of Placebo tablet is as follows: Lactose monohydrate, Polyplasdone, Cellulose microcrystalline, Magnesium stearate, Hypromellose., TRIPTORELIN
Stemline Therapeutics B.V.
patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced breast cancer progressing to endocrine therapy and CDK4/6 inhibitors.
1 trial -
Flecainide or Sotalol or Propafenone
Rhythm Pharmaceuticals Netherlands B.V.
Paroxysmal Atrial Fibrillation
1 trial -
Futibatinib, FULVESTRANT
Taiho Pharma Netherlands B.V.
Malignant Solid Tumors
1 trial -
Givosiran
Alnylam Netherlands B.V.
Acute Hepatic Porphyria
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources